Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter J Gough

Showing results (31-40 of 74) with videos related to

Pageof 8
Sort By:
Cell Death & Disease|February 3, 2017
RIPK1/RIPK3 promotes vascular permeability to allow tumor cell extravasation independent of its necroptotic functionKay Hänggi, Lazaros Vasilikos, Aida Freire Valls, et al.
Cell Reports|March 25, 2015
Structure guided design of potent and selective ponatinib-based hybrid inhibitors for RIPK1Malek Najjar, Chalada Suebsuwong, Soumya S Ray, et al.
Immunity|July 12, 2016
RIPK1 and RIPK3 Kinases Promote Cell-Death-Independent Inflammation by Toll-like Receptor 4Malek Najjar, Danish Saleh, Matija Zelic, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 14, 2014
Cutting Edge: RIP1 kinase activity is dispensable for normal development but is a key regulator of inflammation in SHARPIN-deficient miceScott B Berger, Viera Kasparcova, Sandy Hoffman, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 14, 2014
RIP1 suppresses innate immune necrotic as well as apoptotic cell death during mammalian parturitionWilliam J Kaiser, Lisa P Daley-Bauer, Roshan J Thapa, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 3, 2017
Kinase Activities of RIPK1 and RIPK3 Can Direct IFN-β Synthesis Induced by LipopolysaccharideDanish Saleh, Malek Najjar, Matija Zelic, et al.
Cell Reports|May 13, 2014
MLKL compromises plasma membrane integrity by binding to phosphatidylinositol phosphatesYves Dondelinger, Wim Declercq, Sylvie Montessuit, et al.
Bioorganic & Medicinal Chemistry Letters|May 30, 2015
High throughput screening identifies ATP-competitive inhibitors of the NLRP1 inflammasomePhilip A Harris, Chaya Duraiswami, Donald T Fisher, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 8, 2009
Pharmacological inhibition of C-C chemokine receptor 2 decreases macrophage infiltration in the aortic root of the human C-C chemokine receptor 2/apolipoprotein E-/- mouse: magnetic resonance imaging assessmentAlan R Olzinski, Gregory H Turner, Roberta E Bernard, et al.
Plos One|May 9, 2014
Identification of selective small molecule inhibitors of the nucleotide-binding oligomerization domain 1 (NOD1) signaling pathwayDavid J Rickard, Clark A Sehon, Viera Kasparcova, et al.
Pageof 8

Showing results (31-40 of 74) with videos related to

Sort By:
Pageof 8
Cell Death & Disease|February 3, 2017
RIPK1/RIPK3 promotes vascular permeability to allow tumor cell extravasation independent of its necroptotic functionKay Hänggi, Lazaros Vasilikos, Aida Freire Valls, et al.
Cell Reports|March 25, 2015
Structure guided design of potent and selective ponatinib-based hybrid inhibitors for RIPK1Malek Najjar, Chalada Suebsuwong, Soumya S Ray, et al.
Immunity|July 12, 2016
RIPK1 and RIPK3 Kinases Promote Cell-Death-Independent Inflammation by Toll-like Receptor 4Malek Najjar, Danish Saleh, Matija Zelic, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 14, 2014
Cutting Edge: RIP1 kinase activity is dispensable for normal development but is a key regulator of inflammation in SHARPIN-deficient miceScott B Berger, Viera Kasparcova, Sandy Hoffman, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 14, 2014
RIP1 suppresses innate immune necrotic as well as apoptotic cell death during mammalian parturitionWilliam J Kaiser, Lisa P Daley-Bauer, Roshan J Thapa, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 3, 2017
Kinase Activities of RIPK1 and RIPK3 Can Direct IFN-β Synthesis Induced by LipopolysaccharideDanish Saleh, Malek Najjar, Matija Zelic, et al.
Cell Reports|May 13, 2014
MLKL compromises plasma membrane integrity by binding to phosphatidylinositol phosphatesYves Dondelinger, Wim Declercq, Sylvie Montessuit, et al.
Bioorganic & Medicinal Chemistry Letters|May 30, 2015
High throughput screening identifies ATP-competitive inhibitors of the NLRP1 inflammasomePhilip A Harris, Chaya Duraiswami, Donald T Fisher, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 8, 2009
Pharmacological inhibition of C-C chemokine receptor 2 decreases macrophage infiltration in the aortic root of the human C-C chemokine receptor 2/apolipoprotein E-/- mouse: magnetic resonance imaging assessmentAlan R Olzinski, Gregory H Turner, Roberta E Bernard, et al.
Plos One|May 9, 2014
Identification of selective small molecule inhibitors of the nucleotide-binding oligomerization domain 1 (NOD1) signaling pathwayDavid J Rickard, Clark A Sehon, Viera Kasparcova, et al.
Pageof 8